drugset / Trial / NCT02570022
Liposomal Bupivacaine in Total Shoulder Arthroplasty
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring shoulder arthroplasty will be eligible. The study compares pain control and opioid consumption in patients undergoing shoulder arthroplasty between patients receiving liposomal bupivacaine and those who underwent a preoperative inter-scalene nerve block.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-05
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | — | Other |
Indications
No indication recorded.